...
首页> 外文期刊>Drug discovery today >Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications
【24h】

Induced pluripotent stem cell-derived myeloid phagocytes: disease modeling and therapeutic applications

机译:诱导的多能干细胞来源的髓样吞噬细胞:疾病建模和治疗应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Myeloid phagocytes (neutrophils, monocytes, macrophages and dendritic cells) have key roles in immune defense, as well as in tissue repair and remodeling. Defective or dysregulated myeloid phagocyte production or function can cause immune dysfunction, blood cell malignancies and inflammatory diseases. The tumor microenvironment can also condition myeloid phagocytes to promote tumor growth. Studies of their physiological and pathophysiological roles and the mechanisms regulating their production and function are crucial for the identification of novel therapeutic targets. In this review, we examine the use of induced pluripotent stem cells to study myeloid phagocytes in human diseases and develop future therapeutic strategies.
机译:骨髓吞噬细胞(中性粒细胞,单核细胞,巨噬细胞和树突状细胞)在免疫防御以及组织修复和重塑中起关键作用。骨髓吞噬细胞产生或功能异常或失调可导致免疫功能障碍,血细胞恶性肿瘤和炎症性疾病。肿瘤微环境还可以调节骨髓吞噬细胞以促进肿瘤生长。研究其生理和病理生理作用以及调节其产生和功能的机制对于鉴定新的治疗靶标至关重要。在这篇综述中,我们研究了诱导多能干细胞在人类疾病中研究髓样吞噬细胞的用途,并制定了未来的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号